Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating activities:    
Net income $ 796 $ 563
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 533 219
Amortization of debt discount 5 5
Provision for bad debt expense 57 9
Share-based compensation 414 357
Inventory reserve 8 56
Provision (benefit) for deferred income taxes 138 (163)
(Increase) decrease in operating assets:    
Accounts receivable (5,620) 2,785
Inventories (3,536) (1,610)
Vendor deposits (132) 519
Contract assets 369
Other assets (584) (585)
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses 2,550 (2,068)
Accrued employee expenses (1,836) (94)
Customer deposits 322 532
Contract liabilities 654 (1,260)
Net cash used by operating activities (5,862) (735)
Investing activities:    
Capital expenditures (647) (3)
Cash paid for acquisitions, net of cash acquired (4,294)
Net cash used by investing activities (4,941) (3)
Financing activities:    
Proceeds from borrowings 21,921 603
Debt repayments (10,571) (178)
Net cash provided by financing activities 11,350 425
Net increase (decrease) in cash and cash equivalents 547 (313)
Cash and cash equivalents at beginning of period 1,330 727
Cash and cash equivalents at end of period 1,877 414
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 138 61
Cash paid during the period for income taxes 377 24
Supplemental disclosure of non-cash financing activities    
Common stock issued for acquisitions $ 10,382